1. The composition according to the present invention has the effects of suppressing VEGF expression, reducing tumor cells, reducing MMP-9, and inhibiting oxygen free radicals, among others, thereby having excellent anticancer and antioxidant effects and accelerating treatment when administrated in combination with an anticancer therapeutic agent.

본 발명에 따른 조성물은 우수한 VEGF 발현 저해, 종양세포감소, MMP-9 감소 및 활성산소발생 억제 등의 효과를 가지고 있어, 항암 및 항산화 효과가 뛰어나며, 항암치료제와 병행투여시 치료효과를 촉진시킬 수 있다.